NDC 65302-042
Budesonide Inhalation
Budesonide Inhalation Suspension
Budesonide Inhalation is a Respiratory (inhalation) Suspension in the Human Prescription Drug category. It is labeled and distributed by The Ritedose Corporation. The primary component is Budesonide.
| Product ID | 65302-042_9a27fc4e-5c1e-9e9b-e053-2995a90aaa20 |
| NDC | 65302-042 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Budesonide Inhalation |
| Generic Name | Budesonide Inhalation Suspension |
| Dosage Form | Suspension |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2019-05-21 |
| Marketing Category | ANDA / |
| Application Number | ANDA210897 |
| Labeler Name | The Ritedose Corporation |
| Substance Name | BUDESONIDE |
| Active Ingredient Strength | 1 mg/2mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |